Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-07-11

FDA Approved: DEXTROSE AND ELECTROLYTE NO. 48 — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Dextrose and Electrolyte No. 48, updating the product’s labeling for an IV solution containing sodium lactate, potas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextrose and Electrolyte No. 48 (Sodium lactate, potassium chloride, magnesium chloride, monobasic potassium phosphate, sodium chloride and dextrose monohydrate)

Snippet

SUPPL AP for DEXTROSE AND ELECTROLYTE NO. 48 (SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE)